Wolverine Trading’s Ginkgo Bioworks DNA Stock Holding History

Wolverine Trading’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,654	Closed	-$71.3K	–	4937
2025 Q1	$71.3K	Sell	11,654 -16,920	-59%	-$172K	﹤0.01%	4318
2024 Q4	$270K	Buy	+28,574	New	+$245K	﹤0.01%	4147
2024 Q3	–	Sell	-874	Closed	-$8.76K	–	4905
2024 Q2	$11.7K	Buy	+874	New	+$26.1K	﹤0.01%	4353
2024 Q1	–	Sell	-417	Closed	-$28.2K	–	4675
2023 Q4	$28.2K	Sell	417 -871	-68%	-$53.3K	﹤0.01%	4346
2023 Q3	$93.3K	Buy	1,288 +214	+20%	+$17.1K	﹤0.01%	4015
2023 Q2	$77.8K	Buy	1,074 +647	+152%	+$38.3K	﹤0.01%	3847
2023 Q1	$21K	Buy	427 +72	+20%	+$4.56K	﹤0.01%	3993
2022 Q4	$24K	Sell	355 -847	-70%	-$77.9K	﹤0.01%	3706
2022 Q3	$150K	Buy	1,202 +599	+99%	+$71.4K	﹤0.01%	3751
2022 Q2	$60K	Buy	+603	New	+$73.5K	﹤0.01%	4014
2021 Q4	–	Sell	-545	Closed	-$259K	–	6084
2021 Q3	$266K	Buy	+545	New	+$265K	﹤0.01%	4894

Other funds holding DNA

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

ACG

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wolverine Trading's DNA Position: Q2 2025 in Review

Wolverine Trading sold out of Ginkgo Bioworks (DNA) in Q2 2025, closing a stake of 11,654 shares — an estimated $71.3K sold.

Wolverine Trading first reported a position in DNA in Q3 2021 and held it in 11 quarters. The position peaked at $270K in Q4 2024. 165 funds tracked by Wall St. Rank hold DNA as of Q2 2025.

Wolverine Trading reported no remaining Ginkgo Bioworks position as of Q2 2025 after selling out during the quarter.
Wolverine Trading sold 11,654 Ginkgo Bioworks shares in Q2 2025, an estimated $71.3K.
Wolverine Trading first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 11 quarters.
Wolverine Trading's Ginkgo Bioworks position peaked at $270K in Q4 2024.
165 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.